Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.593, 2009-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Early institution of DMARDs gives better outcome in RA
Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. :
Etanercept considered cost effective vs DMARDs in RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 446, 2004-01 ,pp. :
Herpes Zoster risk increased with DMARDs/oral corticosteroids in RA
Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. :
Is early intervention with biological agents worthwhile in RA?
Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. :
Obesity market to balloon by 2012, new products set to dominate
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 457, 2004-01 ,pp. :